| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/24/2013 | US8541555 Hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers |
| 09/24/2013 | US8541554 Immunosuppressant drug extraction reagent for immunoassays |
| 09/24/2013 | US8541553 Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| 09/24/2013 | US8541552 Antibodies to lymphotoxin-α |
| 09/24/2013 | US8541545 Stabilized melanocortin ligands |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541203 Activatable binding polypeptides and methods of identification and use thereof |
| 09/24/2013 | US8541198 Method for determination and quantification of radiation or genotoxin exposure |
| 09/24/2013 | US8541008 Monoclonal antibody against an ALS1 protein that specifically binds an epitope in an N-terminal domain and which inhibits adherence of Candida albicans to endothelial cells. |
| 09/24/2013 | US8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 09/24/2013 | US8540999 Allergenic proteins and peptides from Japanese cedar pollen |
| 09/24/2013 | US8540997 Complement receptor 1 and 2 fusion proteins |
| 09/24/2013 | US8540996 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof |
| 09/24/2013 | US8540995 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof |
| 09/24/2013 | US8540994 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 09/24/2013 | US8540988 Antibodies that bind polypeptides involved in the process of bone remodeling |
| 09/24/2013 | US8540987 Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody |
| 09/24/2013 | US8540986 Toll-like receptor 3 antagonists |
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2562550C Phosphorylcholine conjugates and corresponding antibodies |
| 09/24/2013 | CA2552788C Fc region variants |
| 09/24/2013 | CA2542691C Il-6 antagonist for use as mesothelioma therapeutic agent |
| 09/24/2013 | CA2515453C Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 09/24/2013 | CA2507099C Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2448427C Molecules and methods for inhibiting shedding of kim-1 |
| 09/24/2013 | CA2446704C Method for preparing human immunoglobulin concentrates for therapeutic use |
| 09/24/2013 | CA2443294C Remedies for infant chronic arthritis-relating diseases |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2417970C 2,5-dkg permeases |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/24/2013 | CA2318857C Use of heregulin as an epithelial cell growth factor |
| 09/24/2013 | CA2312478C G-protein coupled receptors and uses therefor |
| 09/23/2013 | CA2809872A1 Large deletions in human pms2 gene and use thereof |
| 09/20/2013 | CA2809513A1 Process for obtaining an igg composition through heat treatment |
| 09/19/2013 | WO2013138795A1 Cell penetrating compositions for delivery of intracellular antibodies and antibody-like moieties and methods of use |
| 09/19/2013 | WO2013138712A1 Non-human animals expressing ph-sensitive immunoglobulin sequences |
| 09/19/2013 | WO2013138681A1 Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| 09/19/2013 | WO2013138680A1 Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same |
| 09/19/2013 | WO2013138643A1 Soluble engineered monomeric fc |
| 09/19/2013 | WO2013138400A1 Multispecific antigen-binding molecules and uses thereof |
| 09/19/2013 | WO2013137854A1 Antibodies that bind to nanoparticles |
| 09/19/2013 | WO2013137686A1 Gremlin-1 antibody |
| 09/19/2013 | WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF |
| 09/19/2013 | WO2013135930A1 Compounds derived from doxycycline such as haptens, conjugates and antibodies thereof, and immunochemical method for detecting doxycycline |
| 09/19/2013 | WO2013135655A1 Bi-specific adapters |
| 09/19/2013 | WO2013135602A2 Combination therapy for the treatment of ovarian cancer |
| 09/19/2013 | WO2013135588A1 Novel binding molecules with antitumoral activity |
| 09/19/2013 | WO2013134881A1 Generating targeted sequence diversity in fusion proteins |
| 09/19/2013 | WO2013134880A1 Generating targeted sequence diversity in proteins |
| 09/19/2013 | WO2013106586A3 Anti-hla class-ib antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (ivig) useful as therapeutic ivig mimetics and methods of their use |
| 09/19/2013 | WO2013087857A3 Antibodies against c. difficile toxins |
| 09/19/2013 | WO2013086260A4 Combination therapy for treatment of cancer |
| 09/19/2013 | WO2013034660A9 Anti-siglec-15 antibodies and uses thereof |
| 09/19/2013 | WO2012045001A3 Influenza virus antibodies and immunogens and uses therefor |
| 09/19/2013 | US20130245385 Selective anti-hla antibody removal device and methods of production and use thereof |
| 09/19/2013 | US20130245244 Antibodies and Immunotoxins that Target Human Glycoprotein NMB |
| 09/19/2013 | US20130245237 Analysis of Ubiquitinated Polypeptides |
| 09/19/2013 | US20130245236 Antibodies to the chemokine receptor xcr1 |
| 09/19/2013 | US20130245235 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 09/19/2013 | US20130245234 Vmp-like sequences of pathogenic borrelia |
| 09/19/2013 | US20130245233 Multispecific Molecules |
| 09/19/2013 | US20130245232 Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo |
| 09/19/2013 | US20130245230 Unnatural Reactive Amino Acid Genetic Code Additions |
| 09/19/2013 | US20130245229 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245139 Removal of protein aggregates from biopharmaceutical preparations in a flow-through mode |
| 09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
| 09/19/2013 | US20130244925 Molecules mimicking an autoantibody idiotype and compositions containing same |
| 09/19/2013 | US20130244891 Targeted probes of cellular physiology |
| 09/19/2013 | US20130244341 huTNFR1 SELECTIVE ANTAGONISTS |
| 09/19/2013 | US20130244282 Method of producing antibodies |
| 09/19/2013 | US20130244281 Toll-Like Receptor 3 Antagonists |
| 09/19/2013 | US20130244253 Compounds having activity of suppressing activation of tgf-beta receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis c virus |
| 09/19/2013 | US20130243806 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof |
| 09/19/2013 | US20130243803 Therapies, vaccines, and predictive methods for infectious salmon anemia virus |
| 09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
| 09/19/2013 | US20130243795 Human anti-cd27 antibodies, methods and uses |
| 09/19/2013 | US20130243793 Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use |
| 09/19/2013 | US20130243792 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof |
| 09/19/2013 | US20130243789 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 09/19/2013 | US20130243788 Antibodies to tgf-beta |
| 09/19/2013 | US20130243786 Treatment of juvenile rheumatoid arthritis (jra) |
| 09/19/2013 | US20130243783 Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/19/2013 | US20130243779 Peptides protective against e. faecalis, methods and uses relating thereto |
| 09/19/2013 | US20130243778 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/19/2013 | US20130243777 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/19/2013 | US20130243776 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/19/2013 | US20130243775 Multispecific antigen-binding molecules and uses thereof |
| 09/19/2013 | US20130243774 Notch1 binding agents and methods of use thereof |
| 09/19/2013 | US20130243773 Recombinant production of mixtures of antibodies |
| 09/19/2013 | US20130243772 Antibody molecules having specificity for human ox40 |
| 09/19/2013 | US20130243771 Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity in vivo |
| 09/19/2013 | US20130243770 Treating diabetes using inhibitors of il-1 |
| 09/19/2013 | US20130243768 Multimeric proteins and methods of making and using same |
| 09/19/2013 | US20130243767 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/19/2013 | US20130243764 Antigen-binding proteins with increased fcrn binding |
| 09/19/2013 | US20130243763 TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIES |
| 09/19/2013 | US20130243762 Optimized Fc Variants and Methods for Their Generation |